Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 13/20 | 0.46 |
| ▸ | TRPV4 | Q9HBA0 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1003862 | 0.78 | ALDH1A1 (0.46) | ARALDH1A1CYP2A6TSHRPKM | |
| SCHEMBL30361887 | 0.76 | TSHR (0.52) | ARALDH1A1CYP2A6TSHRPKM | |
| SCHEMBL277588 | 0.76 | TSHR (0.52) | ARALDH1A1CYP2A6TSHRPKM | |
| SCHEMBL3076757 | 0.74 | TRPV4 (0.43) | TRPV4ALDH1A1CYP2A6TSHR | |
| SCHEMBL23192730 | 0.73 | AR (0.42) | ARALDH1A1CYP2A6TSHRPKM | |
| SCHEMBL7485092 | 0.73 | MAOB (0.46) | ARTRPV4 | |
| SCHEMBL410587 | 0.73 | TRPV4 (0.57) | ARTRPV4ALDH1A1CYP2A6 | |
| SCHEMBL306406 | 0.73 | AR (0.42) | ARALDH1A1CYP2A6TSHRPKM | |
| SCHEMBL21872468 | 0.73 | AR (0.42) | ARTRPV4ALDH1A1CYP2A6TSHR | |
| SCHEMBL1343600 | 0.73 | AR (0.42) | ARALDH1A1CYP2A6TSHRPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109438512-A | The preparation method of a kind of aromatic alkyl phosphorous oxide type compound | 湖南大学 | 2019-03-08 | — | — | CN | claimed |
| US-20230312481-A1 | SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF | ARBUTUS BIOPHARMA CORP (CA) | 2023-10-05 | — | — | US | disclosed |
| EP-3632443-B1 | ANTI-TUMOR EFFECT POTENTIATOR USING A BIPHENYL COMPOUND | TAIHO PHARMACEUTICAL CO LTD (JP) | 2023-06-07 | — | — | EP | disclosed |
| CN-109438512-A | The preparation method of a kind of aromatic alkyl phosphorous oxide type compound | 湖南大学 | 2019-03-08 | — | — | CN | disclosed |
| WO-2011109679-A2 | INHIBITORS OF 5-LIPOXYGENASE | AMIRA PHARMACEUTICALS, INC. (US) | 2011-09-09 | — | — | WO | disclosed |
| WO-2011109679-A2 | INHIBITORS OF 5-LIPOXYGENASE | AMIRA PHARMACEUTICALS, INC. (US) | 2011-09-09 | — | — | WO | disclosed |
| US-7556918-B2 | Color photographic films comprising support having color developable light sensitive silver halide emulsion layers and color dye-forming couplers, used for high speed print reproduction; storage stability | FUJIFILM CORPORATION (JP) | 2009-07-07 | — | — | US | disclosed |
| US-7425408-B2 | Silver halide color photographic light-sensitive material | FUJIFILM CORPORATION (JP) | 2008-09-16 | — | — | US | disclosed |
| US-20080113305-A1 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | FUJIFILM CORPORATION | 2008-05-15 | — | — | US | disclosed |
| CN-1191657-C | Non-aqueous electrolyte secondary cell | SONY CORP (JP) | 2005-03-02 | — | — | CN | disclosed |
| CN-1568187-A | 2H-2,3-dinitrogen phenodiazine-1-ketone and using method thereof | ICOS CORP (US) | 2005-01-19 | — | — | CN | disclosed |
| CN-1322028-A | Non-aqueous electrolyte secondary cell | SONY CORP (JP) | 2001-11-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312481-A1 | SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF | NSD3, PML, NSD1 | AR 2186/4885TRPV4 4126/4885ALDH1A1 3447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.